Jaekyung Lee

Prof. Jaekyung Lee

orcid
Clinical assistant professor

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in Science Advances
Verified
Journal Article
Open access
JAJunho Ahn
Junho Ahn
JLJaekyung Lee
Jaekyung Lee
Kwangsoon KimKwangsoon Kim
Kwangsoon Kim
JBJa Seong Bae
Ja Seong Bae
Chan Kwon JungChan Kwon Jung
Chan Kwon Jung
Chang-Seok KimChang-Seok Kim
Chang-Seok Kim
Thyroid nodules are primarily diagnosed using ultrasound imaging (USI), but its low specificity leads to unnecessary fine-needle aspiration biopsies (FNABs). In particular, USI’s limited ability to differentiate follicular neoplasms from benign nodules contributes to suboptimal biopsy decision-making. We propose a dual-modal imaging approach that combines multiparametric photoacoustic imaging (PAI) and USI to support smarter biopsy decisions. In 106 patients with 29 benign nodules, 45 papillary thyroid carcinomas, and 32 follicular neoplasms, three PAI-derived parameters—the photoacoustic spectral gradient, oxygen saturation, and skewness of the oxygen saturation distribution—were combined using a support vector machine. Following USI-based American Thyroid Association (ATA) guidelines, they were used to develop the ATA-Photoacoustic (ATAP) scoring system. The ATAP score achieved 97% sensitivity and 38% specificity in distinguishing nodules requiring FNAB. Our approach enabled better identification of benign nodules, reducing unnecessary FNAB in 11 of the 29 benign cases. This dual-modal strategy can assess thyroid nodules, effectively reducing unnecessary biopsies while maintaining high diagnostic accuracy.

26 June 2025 in Endocrine-Related Cancer
Verified
Journal Article
Closed access
JYJungmin Yoo
Jungmin Yoo
MKMijin Kim
Mijin Kim
HKHee Kyung Kim
Hee Kyung Kim
DSDong Yeob Shin
Dong Yeob Shin
MJMin Ji Jeon
Min Ji Jeon
WKWon Gu Kim
Won Gu Kim
We aimed to determine the prevalence and clinical significance of targetable gene fusions in patients with radioiodine-refractory thyroid cancer. This multicenter retrospective cohort study enrolled 111 patients from five tertiary medical centers, with molecular profiling performed using targeted next-generation sequencing. The analysis revealed that 58 (52.3%) patients possessed BRAFV600E mutation, while 25 (22.5%) had RAS mutations. Among the 20 (18.0%) patients with gene fusions, 13 had RET fusions, three had NTRK fusions, one had a BRAF fusion, and three had nondriver gene fusions. The group with targetable gene fusions was significantly younger compared to those with BRAF or RAS mutations (P < 0.001) and predominantly had classic papillary thyroid carcinoma. Furthermore, targetable gene fusions were detected in 30.8% of patients with refractory thyroid cancer harboring wild-type BRAF. More than half of the patients received systemic tyrosine kinase inhibitor therapy and three patients with confirmed RET or NTRK fusions achieved meaningful clinical benefit with selective agents. These findings suggest that a stepwise molecular testing strategy – initiating with BRAF single gene analysis followed by next-generation sequencing for assessing targetable gene fusions – may be a rational approach, particularly for younger patients with papillary thyroid carcinoma, for identifying candidates for precision therapy. This supports the integration of molecular profiling into routine clinical practice for radioiodine-refractory thyroid cancer and emphasizes its utility in guiding personalized treatment decisions in this challenging disease subset.

30 May 2026 in International Journal of Thyroidology
Verified
Journal Article
Open access
PDF file
KSKyung-Hun Sung
Kyung-Hun Sung
JLJaekyung Lee
Jaekyung Lee
SLSeung-Hwan Lee
Seung-Hwan Lee
DLDong-Jun Lim
Dong-Jun Lim
Kyung-Hun Sung, Jaekyung Lee, Seung-Hwan Lee and Dong-Jun Lim. Int J Thyroidol 2026;19:110-3. https://doi.org/10.11106/ijt.2026.19.1.110

1 January 2026 in Journal of Korean Medical Science
Verified
Journal Article
Open access
SBSangjun Bae
Sangjun Bae
JLJeongmin Lee
Jeongmin Lee
JHJeonghoon Ha
Jeonghoon Ha
DLDong-Jun Lim
Dong-Jun Lim
JLJaekyung Lee
Jaekyung Lee